These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 18767289)

  • 61. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Attention-deficit/hyperactivity disorder: an update.
    Pary R; Lewis S; Matuschka PR; Lippmann S
    South Med J; 2002 Jul; 95(7):743-9. PubMed ID: 12144081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 64. Attention-deficit/hyperactivity disorder in children and adolescents: closing diagnostic, communication, and treatment gaps.
    Vierhile A; Robb A; Ryan-Krause P
    J Pediatr Health Care; 2009; 23(1 Suppl):S5-23. PubMed ID: 19084757
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The pathophysiology, medical management, and dental implications of children and young adults having attention-deficit hyperactivity disorder.
    Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
    J Calif Dent Assoc; 2003 Sep; 31(9):669-78. PubMed ID: 14560871
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.
    Bukstein OG
    Expert Rev Neurother; 2006 Apr; 6(4):541-9. PubMed ID: 16623653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Attention-deficit/hyperactivity disorder: evidence-based diagnosis and management for primary care clinicians.
    Liu YH; Stein MT
    Minerva Pediatr; 2004 Dec; 56(6):567-83. PubMed ID: 15765020
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    Noorbala AA; Akhondzadeh S
    Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment with central nervous system stimulants. Practical guidelines].
    Hvolby A; Jørgensen JI
    Ugeskr Laeger; 2004 Jan; 166(3):144-8. PubMed ID: 14870640
    [No Abstract]   [Full Text] [Related]  

  • 70. The challenge of childhood depression and ADHD.
    Manas-Lammers LA
    JAAPA; 2002 Dec; 15(12):31-4, 39-40, 56. PubMed ID: 12555737
    [No Abstract]   [Full Text] [Related]  

  • 71. Attention deficit hyperactivity disorder in prison: a treatment protocol.
    Appelbaum KL
    J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical practice guidelines for attention-deficit/hyperactivity disorder: a review.
    Bukstein OG
    Postgrad Med; 2010 Sep; 122(5):69-77. PubMed ID: 20861590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Attention deficit/hyperactivity disorder: a review and update.
    Cormier E
    J Pediatr Nurs; 2008 Oct; 23(5):345-57. PubMed ID: 18804015
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
    Gruber R
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
    [TBL] [Abstract][Full Text] [Related]  

  • 76. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 77. Attention-deficit/hyperactivity disorder: focus on pharmacologic management.
    Reitz SJ
    J Pediatr Health Care; 1997; 11(2):78-83. PubMed ID: 9155352
    [No Abstract]   [Full Text] [Related]  

  • 78. Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.
    Sangal RB; Sangal JM
    Expert Rev Neurother; 2006 Oct; 6(10):1429-37. PubMed ID: 17078784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beyond methylphenidate: nonstimulant medications for youth with ADHD.
    Wood JG; Crager JL; Delap CM; Heiskell KD
    J Atten Disord; 2007 Nov; 11(3):341-50. PubMed ID: 17932386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.